Reactivation of RASSF1A in breast cancer cells by curcumin

Nutrition and Cancer

Volumn 64, Issue 8, 2012, Pages 1228-1235

  Du, Liping ^a   Xie, Zhiliang ^b   Wu, Lai Chu ^a   Chiu, Ming ^a   Lin, Jiayuh ^c   Chan, Kenneth K ^b   Liu, Shujun ^d   Liu, Zhongfa ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DNA METHYLTRANSFERASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PLACEBO; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SP1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DRUG MECHANISM; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873710074     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.717682     Document Type: Article

References (29)

1. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428, 2002.
2. Fraga MF, Agrelo R, and Esteller M: Cross-talk between aging and cancer: the epigenetic language. Ann N Y Acad Sci 1100, 60-74, 2007.
3. Herceg Z: Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22, 91-103, 2007.
4. Kopelovich L, Crowell JA, and Fay JR: The epigenome as a target for cancer chemoprevention. J Natl Cancer Inst 95, 1747-1757, 2003.
5. Yoo CB and Jones PA: Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5, 37-50, 2006.
6. Szyf M, Pakneshan P, and Rabbani SA: DNAmethylation and breast cancer. Biochem Pharmacol 68, 1187-1197, 2004.
7. Agrawal A, Murphy RF, and Agrawal DK: DNA methylation in breast and colorectal cancers. Mod Pathol 20, 711-721, 2007.
8. Giacinti L, Claudio PP, Lopez M, and Giordano A: Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11, 1-8, 2006.
9. Lehmann U, Langer F, Feist H, Glockner S, Hasemeier B, et al.: Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 160, 605-612, 2002.
10. Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, et al.: HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci USA 98, 9796-9801, 2001.
11. van der Weyden L and Adams DJ: The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776, 58-85, 2007.
12. Shishodia S, Chaturvedi MM, and Aggarwal BB: Role of curcumin in cancer therapy. Curr Probl Cancer 31, 243-305, 2007.
13. Maheshwari RK, Singh AK, Gaddipati J, and Srimal RC: Multiple biological activities of curcumin: a short review. Life Sci 78, 2081-2087, 2006.
14. Singh S and Khar A: Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 6, 259-270, 2006.
15. Hsu CH and Cheng AL: Clinical studies with curcumin. Adv Exp Med Biol 595, 471-480, 2007.
16. Lin JK: Molecular targets of curcumin. Adv Exp Med Biol 595, 227-243, 2007.
17. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, and Aggarwal BB: Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 267, 133-164, 2008.
18. Lopez-Lazaro M: Anticancer and carcinogenic properties of curcumin, considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 52(Suppl 1), S103-S127, 2008.
19. Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, et al.: Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 19, 706-709, 2009.
20. Liu Z, Liu S, Xie Z, Blum W, Perrotti D, et al.: Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method. Nucleic Acids Res 35, e31, 2007.
21. Liu S, Liu Z, Xie Z, Pang J, Yu J, et al.: Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NFkappa B-dependent DNA methyltransferase activity in acute myeloid leukemia. Blood 111, 2364-2373, 2008.
22. Liu Z, Wu J, Xie Z, Liu S, Fan-Havard P, et al.: Quantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry. Anal Biochem 391(2), 106-113, 2009.
23. Liu Z, Liu S, Xie Z, Pavlovicz RE, Wu J, et al.: Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide. J Pharmacol Exp Ther 329(2), 505-514, 2009.
24. Donninger H, Vos MD, and Clark GJ: The RASSF1A tumor suppressor. J Cell Sci 120, 3163-3172, 2007.
25. Moiseeva EP, Almeida GM, Jones GD, and Manson MM: Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 6, 3071-3079, 2007.
26. Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, et al.: Expression profiles of apoptotic genes induced by curcumin in human breast cancer andmammary epithelial cell lines. Anticancer Res 25, 3293-3302, 2005.
27. Niture SK, Velu CS, Smith QR, Bhat GJ, and Srivenugopal KS: Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines. Carcinogenesis 28, 378-389, 2007.
28. Blum W and Marcucci G: Targeting epigenetic changes in acute myeloid leukemia. Clin Adv Hematol Oncol 3, 855-865, 882, 2005.
29. Prasad CP, Rath G, Mathur S, Bhatnagar D, and Ralhan R: Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact 181, 263-271, 2009.